{"ORPHApacket":[{"ORPHApacketID":"2590","date":"2019-12-06 05:25:50","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"2590","Name":[{"lang":"en","label":"Spinal muscular atrophy-progressive myoclonic epilepsy syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_2590","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Progressive myoclonic epilepsy"}],"ORPHA":"98261","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98261"},{"Name":[{"lang":"en","label":"Genetic motor neuron disease"}],"ORPHA":"98505","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98505"},{"Name":[{"lang":"en","label":"Rare myoclonus"}],"ORPHA":"306747","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_306747"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Spinal muscular atrophy-progressive myoclonic epilepsy syndrome is characterized by hereditary myoclonus and progressive distal muscular atrophy. Less than 10 cases have been reported. Treatment with clonazepam results in complete and lasting improvement of the myoclonus."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"159950","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"Hereditary myoclonus-progressive distal muscular atrophy syndrome"},{"lang":"en","label":"Jankovic-Rivera syndrome"},{"lang":"en","label":"SMA-PME"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"N-acylsphingosine amidohydrolase 1"}],"Symbol":"ASAH1","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"735"},{"Source":"OMIM","Reference":"613468"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"7","HPODisorderAssociation":[{"HPOId":"HP:0000726","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000726","HPOTerm":"Dementia","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0001288","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001288","HPOTerm":"Gait disturbance","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002123","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002123","HPOTerm":"Generalized myoclonic seizures","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002167","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002167","HPOTerm":"Neurological speech impairment","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002353","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002353","HPOTerm":"EEG abnormality","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003457","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003457","HPOTerm":"EMG abnormality","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0008955","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0008955","HPOTerm":"Progressive distal muscular atrophy","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}